Niki BioSolutions,

Niki BioSolutions, EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Niki BioSolutions, (NIKI) as of Nov 17, 2026 is -4.37. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was -8.84 — a change of -50.56% (higher).

EV/OCF

-4.37

YoY

-50.56%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Niki BioSolutions, is 2025 -4.37 . EV/OCF (Enterprise Value to Operating Cash Flow) of Niki BioSolutions, was 2024 -8.84 . It decreases by -50.56% higher compared to the previous year.

The Niki BioSolutions, EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2018
-0.53 USD
Jan 1, 2019
-0.62 USD
Jan 1, 2020
1.29 USD
Jan 1, 2021
0.02 USD
Jan 1, 2022
-1.05 USD
Jan 1, 2023
-1.21 USD
Jan 1, 2024
-8.84 USD
Jan 1, 2025
-4.37 USD
The Niki BioSolutions, EV/OCF history
YEAREV/OCFYoY
-4.37-50.56%
-8.84+633.08%
-1.21+15.10%
-1.05-6,416.60%
0.02-98.71%
1.29-308.69%
-0.62+16.61%
-0.53-131.55%
1.68—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Niki BioSolutions, Stock analysis

What does Niki BioSolutions, do? Niki BioSolutions, Inc. is a clinical-stage biopharmaceutical company based in Princeton, US, focused on developing therapeutic products for oncology and infectious diseases. The company operates through a pipeline including SACT-1 (Phase 1 for neuroblastoma), ALS-4 (Phase 1 for bacterial infections), and preclinical candidates like SACT-COV19 and ALS-1 targeting coronavirus and MRSA. It was formerly Aptorum Group Limited, rebranding in July 2026 following its listing on 17 July 2026. Niki BioSolutions, is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Niki BioSolutions, stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Niki BioSolutions, is -4.37 in 2025.

EV/OCF (Enterprise Value to Operating Cash Flow) of Niki BioSolutions, changed from -8.84 to -4.37, representing a -50.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Niki BioSolutions, since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Niki BioSolutions, with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Niki BioSolutions,

All Key Metrics — Niki BioSolutions,